Impact of the IMbrave150 Trial: Evolving Standards of Care for Advanced HCC (Asia-Pacific)
Impact of the IMbrave150 Trial: Evolving Standards of Care for Advanced HCC (Asia-Pacific)
Prof. Pierce KH Chow
View this summary of the July 2020 HCC Experts Round Table meeting (Asia-Pacific) and download the accompanying educational slide set for more information.
Prof. Pierce KH Chow
Liver Surgeon
National Cancer Center Singapore
Singapore
Video | 
5 min
|
Jul 2020
download resources
I agree that this educational programme:
The HCC Experts Round Table (Asia-Pacific) brought together international experts in hepatocellular carcinoma. This interdisciplinary group (oncology, surgical oncology, hepatology, patient advocacy, and health economics) explored evolving standards of care for advanced first-line HCC, particularly in light of IMbrave150 phase III clinical trial data. Follow the link above to view the recent publication announcement from the HCC Experts Round Table.
Other programmes of interest
60 min
